Exact Mass: 539.2552746
Exact Mass Matches: 539.2552746
Found 197 metabolites which its exact mass value is equals to given mass value 539.2552746
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
5,9,11-trihydroxyprosta-6E,14Z-dien-1-oate
5,9,11-trihydroxyprosta-6E,14Z-dien-1-oate, also known as Phorbol 12-(2-methylamino)benzoate 13-acetate or CCRIS 7233, is classified as a member of the Phorbol esters. Phorbol esters are tigliane diterpenoids which are esters of phorbol. 5,9,11-trihydroxyprosta-6E,14Z-dien-1-oate is considered to be practically insoluble (in water) and relatively neutral D009676 - Noxae > D002273 - Carcinogens > D010703 - Phorbol Esters
Nintedanib
C31H33N5O4 (539.2532418000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Chondrochloren B
A monocarboxylic acid amide with formula C28H42ClNO7, that is produced by Chondromyces crocatus and exhibits antibiotic properties.
N1-acetyl-N5,N10-di-(Z,E)-feruloylspermidine
C29H37N3O7 (539.2631372000001)
Nintedanib
C31H33N5O4 (539.2532418000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Ala Met Arg Tyr
Ala Met Tyr Arg
Ala Arg Met Tyr
Ala Arg Tyr Met
Ala Tyr Met Arg
Ala Tyr Arg Met
Cys Arg Val Tyr
Cys Arg Tyr Val
Cys Val Arg Tyr
Cys Val Tyr Arg
Cys Tyr Arg Val
Cys Tyr Val Arg
Glu Lys Thr Tyr
Glu Lys Tyr Thr
Glu Thr Lys Tyr
Glu Thr Tyr Lys
Glu Tyr Lys Thr
Glu Tyr Thr Lys
Phe Met Arg Ser
Phe Met Ser Arg
Phe Arg Met Ser
Phe Arg Ser Met
Phe Ser Met Arg
Phe Ser Arg Met
His Met Pro Arg
His Met Arg Pro
His Asn Asn Arg
C20H33N11O7 (539.2564308000001)
His Asn Arg Asn
C20H33N11O7 (539.2564308000001)
His Pro Met Arg
His Pro Arg Met
His Pro Thr Trp
His Pro Trp Thr
His Arg Met Pro
His Arg Asn Asn
C20H33N11O7 (539.2564308000001)
His Arg Pro Met
His Thr Pro Trp
His Thr Trp Pro
His Trp Pro Thr
His Trp Thr Pro
Lys Glu Thr Tyr
Lys Glu Tyr Thr
Lys Thr Glu Tyr
Lys Thr Tyr Glu
Lys Tyr Glu Thr
Lys Tyr Thr Glu
Met Ala Arg Tyr
Met Ala Tyr Arg
Met Phe Arg Ser
Met Phe Ser Arg
Met His Pro Arg
Met His Arg Pro
Met Pro His Arg
Met Pro Arg His
Met Arg Ala Tyr
Met Arg Phe Ser
Met Arg His Pro
Met Arg Pro His
Met Arg Ser Phe
Met Arg Tyr Ala
Met Ser Phe Arg
Met Ser Arg Phe
Met Tyr Ala Arg
Met Tyr Arg Ala
Asn His Asn Arg
C20H33N11O7 (539.2564308000001)
Asn His Arg Asn
C20H33N11O7 (539.2564308000001)
Asn Asn His Arg
C20H33N11O7 (539.2564308000001)
Asn Asn Arg His
C20H33N11O7 (539.2564308000001)
Asn Arg His Asn
C20H33N11O7 (539.2564308000001)
Asn Arg Asn His
C20H33N11O7 (539.2564308000001)
Pro His Met Arg
Pro His Arg Met
Pro His Thr Trp
Pro His Trp Thr
Pro Met His Arg
Pro Met Arg His
Pro Arg His Met
Pro Arg Met His
Pro Thr His Trp
Pro Thr Trp His
Pro Trp His Thr
Pro Trp Thr His
Arg Ala Met Tyr
Arg Ala Tyr Met
Arg Cys Val Tyr
Arg Cys Tyr Val
Arg Phe Met Ser
Arg Phe Ser Met
Arg His Met Pro
Arg His Asn Asn
C20H33N11O7 (539.2564308000001)
Arg His Pro Met
Arg Met Ala Tyr
Arg Met Phe Ser
Arg Met His Pro
Arg Met Pro His
Arg Met Ser Phe
Arg Met Tyr Ala
Arg Asn His Asn
C20H33N11O7 (539.2564308000001)
Arg Asn Asn His
C20H33N11O7 (539.2564308000001)
Arg Pro His Met
Arg Pro Met His
Arg Ser Phe Met
Arg Ser Met Phe
Arg Val Cys Tyr
Arg Val Tyr Cys
Arg Tyr Ala Met
Arg Tyr Cys Val
Arg Tyr Met Ala
Arg Tyr Val Cys
Ser Phe Met Arg
Ser Phe Arg Met
Ser Met Phe Arg
Ser Met Arg Phe
Ser Arg Phe Met
Ser Arg Met Phe
Thr Glu Lys Tyr
Thr Glu Tyr Lys
Thr His Pro Trp
Thr His Trp Pro
Thr Lys Glu Tyr
Thr Lys Tyr Glu
Thr Pro His Trp
Thr Pro Trp His
Thr Trp His Pro
Thr Trp Pro His
Thr Tyr Glu Lys
Thr Tyr Lys Glu
Val Cys Arg Tyr
Val Cys Tyr Arg
Val Arg Cys Tyr
Val Arg Tyr Cys
Val Tyr Cys Arg
Val Tyr Arg Cys
Trp His Pro Thr
Trp His Thr Pro
Trp Pro His Thr
Trp Pro Thr His
Trp Thr His Pro
Trp Thr Pro His
Tyr Ala Met Arg
Tyr Ala Arg Met
Tyr Cys Arg Val
Tyr Cys Val Arg
Tyr Glu Lys Thr
Tyr Glu Thr Lys
Tyr Lys Glu Thr
Tyr Lys Thr Glu
Tyr Met Ala Arg
Tyr Met Arg Ala
Tyr Arg Ala Met
Tyr Arg Cys Val
Tyr Arg Met Ala
Tyr Arg Val Cys
Tyr Thr Glu Lys
Tyr Thr Lys Glu
Tyr Val Cys Arg
Tyr Val Arg Cys
(E,3R,8S,9S,10R)-N-[(Z)-2-(3-chloro-4-hydroxyphenyl)ethenyl]-2-ethoxy-3,9-dihydroxy-4-methoxy-6,8,10-trimethyl-7-oxotetradec-5-enamide
2-[(1R,8S,14R,15R)-11-hydroxy-14,15-bis[(E)-oct-6-enyl]-3,5,9-trioxo-4,10-dioxatetracyclo[9.4.0.02,6.08,12]pentadeca-2(6),12-dien-8-yl]acetate
N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxynon-4-en-2-yl]acetamide
N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoct-4-en-2-yl]propanamide
Sapintoxin d
A phorbol ester consisting of phorbol that is acylated at positions 12 and 13 by 2-(methylamino)benzoyl and acetyl groups respectively. D009676 - Noxae > D002273 - Carcinogens > D010703 - Phorbol Esters
(1r,2s,3s,5r,6r,8s,10r,12r,13s,14s,16r,17s,18r,19s)-19-benzyl-6,21-dihydroxy-6,8,16,17-tetramethyl-7-oxo-4,11,15-trioxa-20-azahexacyclo[11.8.0.0¹,¹⁸.0³,⁵.0¹⁰,¹².0¹⁴,¹⁶]henicos-20-en-2-yl acetate
methyl (1r,9r,10s,11s,12r,19r)-11-(acetyloxy)-12-ethyl-10-hydroxy-4-[(2r)-5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl]-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,13-tetraene-10-carboxylate
C29H37N3O7 (539.2631372000001)
(1s,2s,3s,5r,6r,8s,10z,13s,14s,16r,17r,18s)-18-benzyl-6,13,20-trihydroxy-6,8,14,16-tetramethyl-7-oxo-4,15-dioxa-19-azapentacyclo[10.8.0.0¹,¹⁷.0³,⁵.0¹⁴,¹⁶]icosa-10,19-dien-2-yl acetate
(1r,2r,3s,5r,6r,8s,10e,12r,13s,14s,16r,17s,18r)-18-benzyl-6,13,20-trihydroxy-6,8,14,16-tetramethyl-7-oxo-4,15-dioxa-19-azapentacyclo[10.8.0.0¹,¹⁷.0³,⁵.0¹⁴,¹⁶]icosa-10,19-dien-2-yl acetate
methyl 11-(acetyloxy)-12-ethyl-10-hydroxy-4-(5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl)-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,13-tetraene-10-carboxylate
C29H37N3O7 (539.2631372000001)
(1r,2s,6r,7s,10s,11r,13s,14r,15r)-13-(acetyloxy)-1,7-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-14-yl 2-(methylamino)benzoate
methyl (1r,9r,10s,11r,12r,19r)-11-(acetyloxy)-12-ethyl-10-hydroxy-4-[(2s)-5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl]-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,13-tetraene-10-carboxylate
C29H37N3O7 (539.2631372000001)
n-[2-(3-chloro-4-hydroxyphenyl)ethenyl]-2-ethoxy-3,9-dihydroxy-4-methoxy-6,8,10-trimethyl-7-oxotetradec-5-enimidic acid
13-(acetyloxy)-1,7-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-14-yl 2-(methylamino)benzoate
19-benzyl-6,21-dihydroxy-6,8,16,17-tetramethyl-7-oxo-4,11,15-trioxa-20-azahexacyclo[11.8.0.0¹,¹⁸.0³,⁵.0¹⁰,¹².0¹⁴,¹⁶]henicos-20-en-2-yl acetate
(1r,2s,3s,5r,6r,8s,10s,12s,13s,14s,16r,17s,18r,19s)-19-benzyl-6,21-dihydroxy-6,8,16,17-tetramethyl-7-oxo-4,11,15-trioxa-20-azahexacyclo[11.8.0.0¹,¹⁸.0³,⁵.0¹⁰,¹².0¹⁴,¹⁶]henicos-20-en-2-yl acetate
(1s,2s,3s,5r,6r,8s,10e,12r,13s,14s,16r,17r,18s)-18-benzyl-6,13,20-trihydroxy-6,8,14,16-tetramethyl-7-oxo-4,15-dioxa-19-azapentacyclo[10.8.0.0¹,¹⁷.0³,⁵.0¹⁴,¹⁶]icosa-10,19-dien-2-yl acetate
(2r,3r,4r,5e,8s,9s,10r)-n-[(1z)-2-(3-chloro-4-hydroxyphenyl)ethenyl]-2-ethoxy-3,9-dihydroxy-4-methoxy-6,8,10-trimethyl-7-oxotetradec-5-enimidic acid
(1r,2s,3s,5r,6r,8s,10s,14s,16r,17s,18r,19s)-19-benzyl-6,21-dihydroxy-6,8,16,17-tetramethyl-7-oxo-4,11,15-trioxa-20-azahexacyclo[11.8.0.0¹,¹⁸.0³,⁵.0¹⁰,¹².0¹⁴,¹⁶]henicos-20-en-2-yl acetate
(1r,2r,6s,7s,10s,11r,13s,14r,15r)-13-(acetyloxy)-1,7-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-14-yl 2-(methylamino)benzoate
methyl (1r,9r,10s,11r,12r,19r)-11-(acetyloxy)-12-ethyl-10-hydroxy-4-[(2r)-5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl]-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,13-tetraene-10-carboxylate
C29H37N3O7 (539.2631372000001)